US Patent Issued to ALECTOS THERAPEUTICS on Jan. 20 for "Non-lysosomal glucosylceramidase inhibitors and uses thereof" (Canadian Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,773, issued on Jan. 20, was assigned to ALECTOS THERAPEUTICS INC. (Canada).

"Non-lysosomal glucosylceramidase inhibitors and uses thereof" was invented by Ramesh Kaul (Burnaby, Canada), Ernest J. Mceachern (Burnaby, Canada), Jianyu Sun (Burnaby, Canada), David J. Vocadlo (Burnaby, Canada), Yuanxi Zhou (Burnaby, Canada) and Yongbao Zhu (Burnaby, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides compounds for inhibiting glucosylceramidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds."

The patent was filed on May 6, 2021, under Application No. 17/923,878. ...